Conmed (CNMD) Revenue Growth (3y) (2013 - 2026)
Conmed (CNMD) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 8.05% |
| 10 | Conmed | 1.54 Bn | 1.51 Bn | 197.46 Mn | 2.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.64% |
| Mar 31, 2026 | 2.38% |
| Dec 31, 2025 | 14.16% |
| Sep 30, 2025 | 7.10% |
| Jun 30, 2025 | 7.29% |
| Mar 31, 2025 | 9.85% |
| Dec 31, 2024 | 8.09% |
| Sep 30, 2024 | 8.37% |
| Jun 30, 2024 | 9.18% |
| Mar 31, 2024 | 10.30% |
| Dec 31, 2023 | 8.96% |
| Sep 30, 2023 | 8.59% |
| Jun 30, 2023 | 26.27% |
| Mar 31, 2023 | 11.35% |
| Dec 31, 2022 | -1.79% |
| Sep 30, 2022 | 5.60% |
| Jun 30, 2022 | 5.17% |
| Mar 31, 2022 | 3.53% |
| Dec 31, 2021 | 4.16% |
| Sep 30, 2021 | 7.14% |